ART4 Gene (ADP-Ribosyltransferase 4)

Gene encoding a glycosylphosphatidylinositol (GPI)-anchored ADP-ribosyltransferase involved in immune regulation and blood group antigen expression.

Gene Information Card

Symbol ART4
Full Name ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)
Gene Type protein-coding
Chromosomal Location 12p12.3
NCBI Gene ID 420 ncbi.nlm.nih.gov/gene/420
Ensembl ID ENSG00000111339
UniProt ID Q93070
OMIM ID 110600
HGNC ID 727
Aliases CD297, DO, Dombrock blood group antigen

Description

ART4 (ADP-ribosyltransferase 4) encodes a glycosylphosphatidylinositol (GPI)-anchored protein that belongs to the ADP-ribosyltransferase family. Although the encoded protein is catalytically inactive due to mutations in the active site, it functions as a cell surface receptor and carries the Dombrock blood group antigens (Doa, Dob, Gya, Hy, Joa). ART4 is expressed on erythrocytes and various immune cells, and its polymorphisms are clinically relevant in transfusion medicine and autoimmune disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Dombrock blood group incompatibility Polymorphisms in ART4 define Dombrock antigens; alloimmunization can occur upon transfusion of incompatible blood. OMIM #110600
Hemolytic transfusion reaction Anti-Dombrock antibodies (anti-Doa, anti-Dob) can cause delayed hemolytic transfusion reactions. ClinVar, NCBI
Autoimmune hemolytic anemia Autoantibodies targeting ART4 may contribute to red blood cell destruction. OMIM, literature
Cancer (potential role) ART4 expression is altered in certain cancers; GPI-anchored proteins may modulate tumor immune evasion. COSMIC, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Whole blood 12.3 Medium
Spleen 8.7 Medium
Bone marrow 6.5 Low
Lung 3.2 Low
Liver 1.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 15.2 High expression
HL-60 (promyeloblast) 11.8 Medium expression
HEK 293 (embryonic kidney) 2.1 Low expression
HeLa (cervical carcinoma) 1.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.793A>G (p.Asn265Asp) missense 0.5% (global) Defines Doa/Dob blood group antigen; alters GPI anchor attachment efficiency.
c.350C>T (p.Thr117Met) missense 0.1% Associated with Hy- phenotype; loss of Hy antigen.
c.442C>T (p.Arg148Trp) missense 0.05% Associated with Jo(a-) phenotype; loss of Joa antigen.
c.624C>G (p.Ile208Met) missense 0.2% Defines Gya antigen; rare in most populations.
Mutation functional classification

Loss of Function (LOF)

Mutations such as c.350C>T (Thr117Met) and c.442C>T (Arg148Trp) disrupt GPI anchor attachment or protein folding, leading to loss of specific Dombrock antigens on the cell surface.

Gain of Function (GOF)

No known gain-of-function mutations reported for ART4.

Dominant Negative (DN)

No dominant-negative effects documented; ART4 functions as a monomeric GPI-anchored protein.

Pathways

ADP-ribosylation (Reactome: R-HSA-196854)
Blood group antigen biosynthesis (Reactome: R-HSA-9033808)
GPI-anchor biosynthesis (Reactome: R-HSA-163125)

Protein Summary

The ART4 protein (UniProt Q93070) is a 314-amino-acid, GPI-anchored cell surface glycoprotein. It is catalytically inactive as an ADP-ribosyltransferase due to substitutions in the NAD+-binding site. The protein carries the Dombrock blood group antigens and is expressed primarily on erythrocytes and hematopoietic cells. Structural polymorphisms define the Doa/Dob, Gya, Hy, and Joa antigens, which are clinically important in transfusion medicine. ART4 may also play a role in immune modulation through its GPI anchor and cell surface localization.

Related Products

Product name Cat.No. Species Gene ID
ART4 Knockout HEK293 Cell Line EDJ-KQ3428 Human 420 Details Get a Quote
ART4 Knockout HeLa Cell Line EDJ-KQ52668 Human 420 Details Get a Quote
ART4 Knockout A-549 Cell Line EDJ-KQ61139 Human 420 Details Get a Quote
ART4 Knockout HCT 116 Cell Line EDJ-KQ69628 Human 420 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: